While opioid drugs provide an excellent painkilling effect throughout operations, they also have side-effects, researchers said.
Post-operative complications, such as respiratory depression, post-operative nausea and vomiting, itching, difficulty going to the toilet and bowel obstruction are well known examples of such side-effects, they said.
"Our results show that patients in the non-opiate group require less painkillers, but receive adequate pain relief. Patients require less analgesics 24 hours after a non-opiate anaesthesia than after an opiate anaesthesia," said Sarah Saxena from Jules Bordet Institute in Belgium.
A randomised controlled trial was conducted, containing two groups each with 33 breast cancer patients undergoing a mastectomy or lumpectomy.
Perioperative non-opiate analgesia was obtained by combining clonidine, ketamine and lidocaine, researchers said.
An extra bolus of ketamine was given if necessary. Opiate analgesia was obtained via a combination of remifentanil infusion, ketamine and lidocaine, they said.
Both groups received intravenous paracetamol and intravenous diclofenac. Patients received a PCA (patient-controlled analgesia) pump for breakthrough pain during the first 24 hours post-operatively.
The total mean piritramide usage 24 hours post-operatively was 8.1 milligrammes (range 2.0-14.5) in the non-opiate group and 13.1 milligrammes (range 6.0-16.0) in the opioid group. The difference observed was statistically significant, researchers said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
